Discounted Cash Flow
Inspire Medical Systems, Inc.
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2017 | $28.6m | $-17.5m | $-16.2m | -61.3% | — |
| 2018 | $50.6m (77.1%) | $-21.8m (-24.7%) | $-18.9m (-16.9%) | -43.1% (29.6%) | — |
| 2019 | $82.0m (62.2%) | $-33.2m (-52.3%) | $-35.6m (-87.8%) | -40.5% (6.1%) | $-1.40 |
| 2020 | $115.4m (40.6%) | $-57.2m (-72.1%) | $-55.5m (-56.0%) | -49.6% (-22.4%) | $-2.19 (-56.4%) |
| 2021 | $233.4m (102.3%) | $-42.0m (26.5%) | $-24.8m (55.3%) | -18.0% (63.7%) | $-1.54 (29.7%) |
| 2022 | $407.9m (74.7%) | $-44.9m (-6.8%) | $2.5m (110.0%) | -11.0% (38.9%) | $-1.60 (-3.9%) |
| 2023 | $624.8m (53.2%) | $-21.2m (52.9%) | $1.0m (-58.6%) | -3.4% (69.2%) | $-0.72 (55.0%) |
| 2024 | $802.8m (28.5%) | $53.5m (353.0%) | $91.1m (8798.7%) | 6.7% (296.9%) | $1.80 (349.7%) |
| 2025 | $912.0m (13.6%) | $145.4m (171.8%) | $78.5m (-13.9%) | 15.9% (139.2%) | $4.95 (175.4%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.